HYDERABAD: Elon Musk’s brain-implant start Neuralink has been approved by the US Food and Drug Administration. The company’s first human clinical trial can now be commenced, the agency said.
Founded by Musk in 2016, the neurotechnology company is developing an implantable brain-computer interface(BCI) which could help in treatment of neurological disorders.
Apart from aiding in treatment, the BCI can improve cognition in humans.
The company has taken to Twitter to share the news. It tweeted from its official account, saying, "We are excited to share that we have received the FDA’s Approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. (Sic)"
Musk, during a demonstration earlier, had shown a video of a monkey with a Neuralink brain implant, using his mind to move a cursor of images of letters, and called it the "telepathic thinking".